Advertisement
U.S. markets open in 5 hours 16 minutes

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.8510+0.0710 (+9.10%)
At close: 04:00PM EDT
0.8600 +0.01 (+1.06%)
After hours: 07:28PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/19/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
152.25M96.35M106.23M230.20M302.32M514.58M
Enterprise Value
109.35M-783.39k-496.39k62.51M67.79M240.72M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
0.840.460.460.862.444.19
Price/Book (mrq)
1.840.710.460.691.021.69
Enterprise Value/Revenue
0.62-0.38-0.059.150.438.84
Enterprise Value/EBITDA
-1.130.010.01-0.950.82-4.82

Trading Information

Stock Price History

Beta (5Y Monthly) 1.44
52-Week Change 3-55.26%
S&P500 52-Week Change 328.64%
52 Week High 32.0000
52 Week Low 30.2900
50-Day Moving Average 30.7368
200-Day Moving Average 30.8006

Share Statistics

Avg Vol (3 month) 32.26M
Avg Vol (10 day) 31.9M
Shares Outstanding 5178.91M
Implied Shares Outstanding 6178.91M
Float 8163.16M
% Held by Insiders 110.72%
% Held by Institutions 149.66%
Shares Short (Feb 29, 2024) 410.06M
Short Ratio (Feb 29, 2024) 43.03
Short % of Float (Feb 29, 2024) 46.61%
Short % of Shares Outstanding (Feb 29, 2024) 45.67%
Shares Short (prior month Jan 31, 2024) 49.98M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -146.30%
Operating Margin (ttm)-2,476.15%

Management Effectiveness

Return on Assets (ttm)-17.60%
Return on Equity (ttm)-136.47%

Income Statement

Revenue (ttm)176.23M
Revenue Per Share (ttm)1.01
Quarterly Revenue Growth (yoy)-92.50%
Gross Profit (ttm)N/A
EBITDA -87.43M
Net Income Avi to Common (ttm)-257.83M
Diluted EPS (ttm)-1.4800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)81M
Total Cash Per Share (mrq)0.45
Total Debt (mrq)38.1M
Total Debt/Equity (mrq)45.97%
Current Ratio (mrq)1.98
Book Value Per Share (mrq)0.47

Cash Flow Statement

Operating Cash Flow (ttm)-224.84M
Levered Free Cash Flow (ttm)-90.74M